Found 487 clinical trials
Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the novel coronavirus disease 2019 (COVID-19) pandemic. Among COVID-19 complications, in-hospital cardiac arrest (IHCA) was reported with a very poor outcome in a retrospective single-center study (0,7% of 30 days survival with good neurological outcome among IHCA patients with a …
- 0 views
- 19 Feb, 2024
- 41 locations
Sequelae of Sars-CoV-2 Infections
By the end of 2019 a new coronavirus, named SARS-CoV-2, was discovered in patients with pneumonia in Wuhan, China. In the following weeks and months the virus spread globally, having a tremendous impact on global health and economy.
- 0 views
- 19 Feb, 2024
- 1 location
Rapid Diagnostic Profiling of SARS-CoV-2 (COVID-19)
Hence, this project will evaluate the performance of various rapid diagnostic tests (RDTs) for SARS-CoV-2, taking into account the above-determined immune system characteristics.
- 0 views
- 19 Feb, 2024
- 1 location
Determinants of SARS-COV2 (COVID-19) Persistence After Convalescence
The 2019-2020 COVID-19 pandemic is the largest outbreak in recent history. It is not known how long after someone gets sick with COVID-19 and recovers that they can still infect other people. It is also not known how quickly people make antibodies against the virus, which help clear infection from …
- 0 views
- 19 Feb, 2024
- 1 location
Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection
In particular defining severity with objective testing and determining if this has any predictive value on the outcome of the SARS CoV-2 infection. In addition, this study will strive to determine duration / natural history of olfactory dysfunction in these patients in respect to a positive SARS CoV-2 diagnosis.
- 0 views
- 19 Feb, 2024
- 3 locations
Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins
SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), has negatively impacted global health and requires more research to develop better tests and to improve disease treatment.
- 0 views
- 19 Feb, 2024
- 1 location
Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19)
People with cancer may be at higher risk of poor outcomes with COVID-19 infection. This observational study aims to describe the clinical course of COVID-19 infection in people with cancer and evaluate the utility of antibody and antigen tests for COVID-19. The results of this study will inform clinical practice …
- 0 views
- 19 Feb, 2024
- 1 location
Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19
Approximately 15% of patients with SARS-CoV-2 infection / COVID-19 develop a severe clinical course. This leads to hospitalization and potentially life threatening complications such as pneumonia and respiratory failure.
- 0 views
- 19 Feb, 2024
- 1 location
Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19.
SARS-CoV-2 CD4/CD8 T cell response (CTL) Different KIR phenotypes
- 0 views
- 19 Feb, 2024
- 1 location
Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1b
The Canadian Paediatric Society recommends breastfeeding during COVID-19 infection. Human milk is the best form of infant nutrition providing significant protection against many illnesses for term and preterm infants. When mothers of hospitalized infants are unable to supply their milk, the recommended supplement is human donor milk. The impact of …
- 0 views
- 19 Feb, 2024
- 1 location